Davy Global Fund Management Ltd
- SEC CIK
- 0001620943
- Latest filing
- Jul 31, 2026
LAB holding history
Standard Biotools Inc. in every 13F filed by Davy Global Fund Management Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LAB overviewAll 13F holders of LABFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −108,416−100.0% | Sold out | Holders |
| Q4 2025 | 108,416 | $138.8K | <0.1% | +35,069+47.8% | Added | Holders |
| Q3 2025 | 73,347 | $95.4K | <0.1% | +28,050+61.9% | Added | Holders |
| Q2 2025 | 45,297 | $54.4K | <0.1% | +18,178+67.0% | Added | Holders |
| Q1 2025 | 27,119 | $29.3K | <0.1% | +14,541+115.6% | Added | Holders |
| Q4 2024 | 12,578 | $22.0K | <0.1% | −7,148−36.2% | Reduced | Holders |
| Q3 2024 | 19,726 | $38.1K | <0.1% | −2,246−10.2% | Reduced | Holders |
| Q2 2024 | 21,972 | $38.9K | <0.1% | +21,972 | New | Holders |